LENZ (NASDAQ: LENZ) director awarded 22,100 stock options at $6.63 strike
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
LENZ Therapeutics director Kimberlee C. Drapkin received a stock option grant for 22,100 shares of common stock at an exercise price of $6.63 per share. The option expires on June 15, 2036 and represents a compensation-related award, not an open-market purchase or sale.
All 22,100 option shares vest in a single installment, provided she continues to serve as an Outside Director. Vesting occurs on the earlier of June 15, 2027 or the date of the next annual meeting of stockholders. Following this grant, she holds 22,100 options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Drapkin Kimberlee C
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 22,100 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 22,100 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 22,100 options
Exercise price: $6.63 per share
Expiration date: June 15, 2036
+2 more
5 metrics
Options granted
22,100 options
Stock option award to director on June 15, 2026
Exercise price
$6.63 per share
Strike price for 22,100 LENZ common shares
Expiration date
June 15, 2036
Option term end date
Total derivative holdings
22,100 options
Total shares following transaction reported as options
Cliff vesting date
June 15, 2027
Latest possible vesting date, or earlier next annual meeting
Key Terms
Stock Option (right to buy), Outside Director, exercise price, expiration date, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
Outside Director financial
"Subject to the Reporting Person continuing to be an Outside Director"
exercise price financial
"conversion_or_exercise_price": "6.6300""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date": "2036-06-15T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"one hundred percent (100%) of the shares subject to the option shall vest"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What did LENZ (LENZ) director Kimberlee C. Drapkin report on this Form 4?
She reported receiving a grant of stock options for 22,100 shares of LENZ common stock at a $6.63 exercise price. This is a compensation award, not an open-market trade, and increases her derivative holdings to 22,100 options.
Is the LENZ (LENZ) Form 4 transaction a stock purchase or sale?
The Form 4 shows a grant of stock options, not a market purchase or sale. The transaction code "A" identifies it as an award acquisition, providing the director rights to buy 22,100 shares at $6.63 if the options vest and are exercised.
What are the key terms of Kimberlee Drapkin’s LENZ stock options?
The options cover 22,100 underlying common shares with a $6.63 exercise price and expire on June 15, 2036. All shares vest together if she remains an Outside Director until June 15, 2027 or the next annual stockholder meeting, whichever occurs first.
When do the LENZ (LENZ) director stock options vest according to the filing?
Vesting is cliff-based: 100% of the 22,100 option shares vest on the earlier of June 15, 2027 or the date of the next annual stockholder meeting. Vesting requires she continue serving as an Outside Director through that applicable date under the company’s compensation policy.